News items related to:
-
Estimated costs and prices of essential medicines
Research from the University of Liverpool estimates the costs of production and potential prices for drugs on the WHO’s Essential...
-
Global Summit on IP and Access to Medicines – 2018
All the presentations from our inaugural GSIPA2M in Marrakech, January 2018.
-
Big Pharma Drop the Case!
Argentina and Brazil launch a campaign to demand that pharmaceutical companies drop their case which threatens access to medicines and...
-
At the Edge of a Miracle: The Hepatitis C Virus (HCV) Epidemic in Malaysia
The hepatitis C virus (HCV) has long since been a neglected disease. However, of late, given the development of revolutionary...
-
The Roadmap – Special Edition Report on Dolutegravir
The Initiative for Medicines, Access and Knowledge (I-MAK), has published a special edition ‘Roadmap report’ on dolutegravir. The report provides...
-
UN Secretary General’s High Level Panel on access to medicines report
Report: Promoting innovation and access to health technologies.
-
How to Conduct Patent Searches for Medicines
This guide helps to identify whether patents related to a pharmaceutical product exist in the country of interest. This is...
-
Glossary of Patent Terminology
This document provides a list of patent terminology published by the OECD in 2006.
-
Public Health Related Trips-Plus Provisions in Bilateral Trade Agreements
This policy guide highlights the adverse effects of bilateral trade agreements on public health and access to medicines in the...
-
World Trade Organization – TRIPS Agreement
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).